Janssen’s company group chairman dishes on growth strategy
Welcome to Pharma50Talks! Drug Discovery & Development has returned with this year’s edition of the Pharma50.
In this third episode, Pharma Editor Brian Buntz got a chance to sit down with Tom Cavanaugh, Janssen’s Company Group Chairman, Global Commercial Strategy Organization, to talk about the company’s growth strategy. Tom walks us through some of the drugs that helped fuel Janssen’s international sales growth, the history of company’s pathway approach, how the company is prioritizing the increase in funding, what sets Janssen apart in the pharma space, and much more!
Full recap of the discussion can be found, HERE. https://www.drugdiscoverytrends.com/janssen-company-group-chairman-dishes-on-growth-strategy/
To view the rest of the features of this year’s Pharma50 such as:
– The 50 largest pharmaceutical companies in the world
– Pharma’s top 20 R&D spenders in 2021
– 50 of 2021’s best-selling pharmaceuticals
– The 15 best pharma companies to work for
– 10 leading pharma executives
– 50 leading cell and gene therapy companies
